Insulin Glulisine

Preferred Label : Insulin Glulisine;

NCIt related terms : Apidra;

Alternative definition : NCI-GLOSS: A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the laboratory. Insulin glulisine gets into the blood faster than insulin when it is injected under the skin before or shortly after a meal. It is a type of therapeutic insulin.;

UNII : 7XIY785AZD;

CAS number : 207748-29-6;

Chemical formula : C258H384N64O78S6;

Codes from synonyms : CDR0000658827; CDR0000658828;

Détails

Origin ID

C65921;

UMLS CUI

C1313386;

Automatic exact mappings (from CISMeF team)
- Apidra [MeSH concept]
See also inter- (CISMeF)
- Product containing insulin glulisine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Insulin glulisine (substance) [SNOMED CT concept]
- Product containing insulin glulisine (medicinal product) [SNOMED CT concept]
- insulin glulisine [ATC Code]
- insulin glulisine [Substance BNPC]
- insulin glulisine [MeSH concept]
- insulin glulisine [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- insulin glulisine [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients